Stephen T. Oh

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial”.

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature Medicine(2021)10.1038/s41591-021-01539-8

N/A

4.0DataRank · unranked

147 citations

Andreas Reiter, Deepti Radia, Michael W. Deininger, Tracy I. George, Jens Panse +19 more

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-025-03572-3

N/A

0.664DataRank · unranked

40 citations

Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds +23 more

Spatial Mapping of Hematopoietic Clones in Human Bone Marrow

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0110

N/A

0.487DataRank · unranked

8 citations

Hannah C. Davis, Maggie J. Cox, Tyler M. Parsons, Samantha C. Burkart, Diane E. Bender +4 more

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.27.449656

N/A

0DataRank · unranked

14 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Anthony Z. Wang +8 more

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

Nature Cancer(2022)10.1038/s43018-022-00486-8

N/A

0DataRank · unranked

40 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Laure Poittevin De La Frégonnière +10 more

Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib

British Journal of Haematology(2022)10.1111/bjh.18044

N/A

0DataRank · unranked

21 citations

Tim Kong, Jared S. Fowles, Chun‐Ling Jung, Maggie J. Allen, Daniel A.C. Fisher +5 more

Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes

Experimental Hematology(2022)10.1016/j.exphem.2022.03.011

N/A

0DataRank · unranked

12 citations

Darlene Monlish, Zev J. Greenberg, Daniel A.C. Fisher, Matthew J. Walter, Stephen T. Oh +2 more

Multiomic Profiling Reveals Metabolic Alterations Mediating Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.08.519689

N/A

0DataRank · unranked

4 citations

Angelo B. A. Laranjeira, Tim Kong, Alice Liu, Katrina Ashworth, Nina Lasky +10 more

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry

Nature Communications(2023)10.1038/s41467-023-37123-6

N/A

0DataRank · unranked

61 citations

Karolyn A. Oetjen, Diane E. Bender, Marianna B. Ruzinova, Daniel A.C. Fisher, Kevin G. Shim +6 more

Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms

Journal of Clinical Investigation(2023)10.1172/jci172256

N/A

0DataRank · unranked

43 citations

Angelo B. A. Laranjeira, Tim Kong, Shuyang Lin, Katrina Ashworth, Alice Liu +13 more

Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms

American Journal of Hematology(2023)10.1002/ajh.26935

N/A

0DataRank · unranked

15 citations

LaYow Yu, Angelo B. A. Laranjeira, Daniel A.C. Fisher, Fan He, Maggie J. Cox +2 more

Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice

Experimental Hematology(2023)10.1016/j.exphem.2023.08.005

N/A

0DataRank · unranked

2 citations

Angelo B. A. Laranjeira, Tim Kong, Steven C. Snyder, Kevin G. Shim, Mary C. Fulbright +2 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

RSK1 dependency in FLT3-ITD acute myeloid leukemia

Blood Cancer Journal(2024)10.1038/s41408-024-01187-4

N/A

0DataRank · unranked

9 citations

Angelo B. A. Laranjeira, Christopher T. Letson, LaYow Yu, Fan He, Aarthi Jayanthan +5 more

Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3468

N/A

0DataRank · unranked

8 citations

J. Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C.C. Chan, Zilan Xin +13 more

Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms

Experimental Hematology(2024)10.1016/j.exphem.2024.104178

N/A

0DataRank · unranked

2 citations

Angelo B. A. Laranjeira, Tim Kong, Mary C. Fulbright, Daniel A.C. Fisher, Christopher M. Sturgeon +3 more

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response

Leukemia(2024)10.1038/s41375-024-02426-0

N/A

0DataRank · unranked

0 citations

Eric D Duncavage, Ajay Khanna, Gue Su Chang, Sridhar Nonavinkere Srivatsan, Christopher A. Miller +22 more

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia

Nature Communications(2025)10.1038/s41467-024-55643-7

N/A

0DataRank · unranked

17 citations

Angelo B. A. Laranjeira, Christopher T. Letson, LaYow Yu, Shuyang Lin, Jared S. Fowles +20 more

A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies

Cell Communication and Signaling(2025)10.1186/s12964-025-02568-3

N/A

0DataRank · unranked

1 citations

Shuyang Lin, Bei Gao, Varun Ramesh, Alexander B. Kim, Tim Kong +10 more

Parallel Evolution of Leukemic Clones in Myeloproliferative Neoplasms

Research Square(2025)10.21203/rs.3.rs-8097141/v1

N/A

0DataRank · unranked

1 citations

Tyler M. Parsons, Aishwarya Krishnan, Infencia Xavier Raj, Andrew L. Young, David R O’Leary +4 more

Unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.07.674755

N/A

0DataRank · unranked

0 citations

Sang-Eun Jung, Harikrishna Paik, Yesenia Earth, Jiye Yi, Maggie J. Cox +4 more

JAK2 V617F Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.23.678057

N/A

0DataRank · unranked

0 citations

Aishwarya Krishnan, Infencia Xavier Raj, Andrew L. Young, David R O’Leary, Jason Arand +4 more

A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1652

N/A

0DataRank · unranked

32 citations

Ethan Krug, Christine R. Zhang, Wentao Han, Nancy Issa, Won Kyun Koh +12 more

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

JCI Insight(2021)10.1172/jci.insight.128456

N/A

0DataRank · unranked

29 citations

Arijita Jash, Olga Malkova, Diane D. Mao, Patrick DeSouza, Yunli E. Chu +9 more